Mutations in the KDM6A gene, mostly deletions and truncations, are observed in 3–20% of PDAC samples, and the pancreatic-specific deletion of Kdm6a in mice leads to greatly accelerated Kras-driven pancreatic cancer [8,13,94,95]. This evidence concerns the gene KRAS and pancreatic neoplasm.